Semaphorin-3C (SEMA3C) Antibody

Este producto es parte de SEMA3 - semaphorin 3
Semaphorin-3C (SEMA3C) Antibody
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Semaphorin-3C (SEMA3C) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx348747
Tested Applications
ELISA, IHC

Description

Semaphorin-3C (SEMA3C) Antibody is a Rabbit Polyclonal antibody for the detection of Human SEMA3C.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Semaphorin-3C (SEMA3C)
Immunogen: Recombinant Human Semaphorin-3C protein (292-396 AA)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G chromatography.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q99985
Gene ID
10512
OMIM
602645
Alias
SemE,SEMAE,Semaphorin-E
Background
Antibody anti-SEMA3C
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

SEMA3C (Semaphorin 3C) is another key member of the class 3 semaphorins, primarily involved in neuronal pathfinding, cardiovascular development, and cancer biology. SEMA3C signals through neuropilin-2 (NRP2) and plexin receptors to regulate cellular behaviors such as migration, invasion, and adhesion. In cancer, SEMA3C is frequently upregulated, where it promotes tumor growth and metastasis by facilitating angiogenesis and modulating the tumor microenvironment. Its dual roles in development and oncogenesis make it a compelling target for both regenerative medicine and oncology.